Wulandari Harahap P, Putra Tarigan S, Novisari Soeroso N. Adverse Event Of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Treatment In Medan Among Pulmonary Adenocarcinoma: Focus On Non-Hematologic Toxicity. IJHP [Internet]. 2025 Aug. 26 [cited 2025 Sep. 27];5(3):422-9. Available from: https://ijhp.net/index.php/IJHP/article/view/429